TreeWAS – Variant ID: rs927833

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
W19.9 Unspecified place	0.000	0.985	0.015
R17 Unspecified jaundice	0.015	0.985	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.014	0.986	0.000
G40 Epilepsy	0.013	0.987	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.012	0.988	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.012	0.988	0.000
G40-G47 Episodic and paroxysmal disorders	0.011	0.989	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.011	0.989	0.000
H66.9 Otitis media, unspecified	0.000	0.989	0.011
D86.9 Sarcoidosis, unspecified	0.000	0.989	0.011
N92.3 Ovulation bleeding	0.000	0.990	0.010
H66 Suppurative and unspecified otitis media	0.000	0.990	0.010
G40.7 Petit mal, unspecified, without grand mal seizures	0.010	0.990	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.010	0.990	0.000
G40.5 Special epileptic syndromes	0.010	0.990	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.990	0.010
G40.4 Other generalised epilepsy and epileptic syndromes	0.009	0.991	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.009	0.991	0.000
H73 Other disorders of tympanic membrane	0.000	0.991	0.009
H65-H75 Diseases of middle ear and mastoid	0.000	0.991	0.009
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.009	0.991	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.009	0.991	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.991	0.009
G47 Sleep disorders	0.009	0.991	0.000
G43 Migraine	0.009	0.991	0.000
G43.9 Migraine, unspecified	0.009	0.991	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.991	0.008
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.992	0.008
H66.3 Other chronic suppurative otitis media	0.000	0.992	0.008
G40.8 Other epilepsy	0.008	0.992	0.000
G46 Vascular syndromes of brain in cerebrovascular diseases	0.008	0.992	0.000
G44 Other headache syndromes	0.008	0.992	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.008	0.992	0.000
G45.1 Carotid artery syndrome (hemispheric)	0.008	0.992	0.000
G45.0 Vertebro-basilar artery syndrome	0.008	0.992	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.008	0.992	0.000
H72 Perforation of tympanic membrane	0.000	0.992	0.008
G41 Status epilepticus	0.007	0.992	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.992	0.008
H66.4 Suppurative otitis media, unspecified	0.000	0.992	0.007
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.992	0.007
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.992	0.007
H66.0 Acute suppurative otitis media	0.000	0.992	0.007
H74.4 Polyp of middle ear	0.000	0.993	0.007
G47.9 Sleep disorder, unspecified	0.007	0.993	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.993	0.007
H68 Eustachian salpingitis and obstruction	0.000	0.993	0.007
H67 Otitis media in diseases classified elsewhere	0.000	0.993	0.007
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.993	0.007
H73.1 Chronic myringitis	0.000	0.993	0.007
H73.0 Acute myringitis	0.000	0.993	0.007
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.993	0.007
H70 Mastoiditis and related conditions	0.000	0.993	0.007
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.993	0.007
H74.1 Adhesive middle ear disease	0.000	0.993	0.007
H69 Other disorders of Eustachian tube	0.000	0.993	0.007
G45.3 Amaurosis fugax	0.007	0.993	0.000
G47.4 Narcolepsy and cataplexy	0.007	0.993	0.000
G47.2 Disorders of the sleep-wake schedule	0.007	0.993	0.000
G44.2 Tension-type headache	0.007	0.993	0.000
H65 Nonsuppurative otitis media	0.000	0.993	0.007
G43.3 Complicated migraine	0.007	0.993	0.000
G43.2 Status migrainosus	0.007	0.993	0.000
G43.0 Migraine without aura [common migraine]	0.007	0.993	0.000
H74.0 Tympanosclerosis	0.000	0.993	0.007
G47.1 Disorders of excessive somnolence [hypersomnias]	0.007	0.993	0.000
G47.8 Other sleep disorders	0.007	0.993	0.000
G47.3 Sleep apnoea	0.007	0.993	0.000
G43.1 Migraine with aura [classical migraine]	0.006	0.994	0.000
G46.8 Other vascular syndromes of brain in cerebrovascular diseases	0.006	0.994	0.000
G46.7 Other lacunar syndromes	0.006	0.994	0.000
G46.6 Pure sensory lacunar syndrome	0.006	0.994	0.000
G46.5 Pure motor lacunar syndrome	0.006	0.994	0.000
G46.4 Cerebellar stroke syndrome	0.006	0.994	0.000
G46.3 Brain stem stroke syndrome	0.006	0.994	0.000
G46.2 Posterior cerebral artery syndrome	0.006	0.994	0.000
G46.1 Anterior cerebral artery syndrome	0.006	0.994	0.000
G46.0 Middle cerebral artery syndrome	0.006	0.994	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.994	0.006
G44.0 Cluster headache syndrome	0.006	0.994	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.006	0.994	0.000
G44.3 Chronic posttraumatic headache	0.006	0.994	0.000
G44.1 Vascular headache, not elsewhere classified	0.006	0.994	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.994	0.006
H65.2 Chronic serous otitis media	0.000	0.994	0.006
H72.2 Other marginal perforations of tympanic membrane	0.000	0.994	0.006
H72.1 Attic perforation of tympanic membrane	0.000	0.994	0.006
G41.8 Other status epilepticus	0.005	0.994	0.000
G41.2 Complex partial status epilepticus	0.005	0.994	0.000
G41.1 Petit mal status epilepticus	0.005	0.994	0.000
G41.0 Grand mal status epilepticus	0.005	0.994	0.000
G43.8 Other migraine	0.005	0.994	0.000
H69.9 Eustachian tube disorder, unspecified	0.000	0.995	0.005
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.995	0.005
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.995	0.005
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.995	0.005
H68.1 Obstruction of Eustachian tube	0.000	0.995	0.005
H68.0 Eustachian salpingitis	0.000	0.995	0.005
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.995	0.005
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.995	0.005
H70.8 Other mastoiditis and related conditions	0.000	0.995	0.005
H70.2 Petrositis	0.000	0.995	0.005
H70.1 Chronic mastoiditis	0.000	0.995	0.005
H70.0 Acute mastoiditis	0.000	0.995	0.005
H69.0 Patulous Eustachian tube	0.000	0.995	0.005
H70.9 Mastoiditis, unspecified	0.000	0.995	0.005
H65.1 Other acute nonsuppurative otitis media	0.000	0.995	0.005
H65.0 Acute serous otitis media	0.000	0.995	0.005
H69.8 Other specified disorders of Eustachian tube	0.000	0.995	0.005
G41.9 Status epilepticus, unspecified	0.005	0.995	0.000
E14.9 Without complications	0.000	0.995	0.005
G45.4 Transient global amnesia	0.005	0.995	0.000
G44.8 Other specified headache syndromes	0.005	0.995	0.000
D86 Sarcoidosis	0.000	0.995	0.005
S22.30 Fracture of rib (closed)	0.004	0.996	0.000
H71 Cholesteatoma of middle ear	0.000	0.996	0.004
H65.4 Other chronic nonsuppurative otitis media	0.000	0.996	0.004
G81.9 Hemiplegia, unspecified	0.004	0.996	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.996	0.004
G83.2 Monoplegia of upper limb	0.004	0.996	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.996	0.004
D86.3 Sarcoidosis of skin	0.000	0.996	0.004
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.996	0.004
G40.9 Epilepsy, unspecified	0.004	0.996	0.000
N36.8 Other specified disorders of urethra	0.000	0.996	0.004
S22.3 Fracture of rib	0.004	0.996	0.000
G81 Hemiplegia	0.004	0.996	0.000
S32.50 Fracture of pubis (closed)	0.004	0.996	0.000
L60.0 Ingrowing nail	0.000	0.996	0.004
S22.00 Fracture of thoracic vertebra (closed)	0.003	0.996	0.000
G83 Other paralytic syndromes	0.003	0.997	0.000
H65.3 Chronic mucoid otitis media	0.000	0.997	0.003
S22.0 Fracture of thoracic vertebra	0.003	0.997	0.000
G83.8 Other specified paralytic syndromes	0.003	0.997	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.003	0.997	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.003	0.997	0.000
G83.9 Paralytic syndrome, unspecified	0.003	0.997	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.003	0.997	0.000
S22.2 Fracture of sternum	0.003	0.997	0.000
E14 Unspecified diabetes mellitus	0.000	0.997	0.003
D86.0 Sarcoidosis of lung	0.000	0.997	0.003
G81.1 Spastic hemiplegia	0.003	0.997	0.000
S22.20 Fracture of sternum (closed)	0.003	0.997	0.000
W19 Unspecified fall	0.000	0.997	0.003
S22.31 Fracture of rib (open)	0.003	0.997	0.000
G81.0 Flaccid hemiplegia	0.003	0.997	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.997	0.003
M67.43 Ganglion, wrist	0.003	0.997	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.003	0.997	0.000
G83.5 Locked-in syndrome	0.003	0.997	0.000
G83.3 Monoplegia, unspecified	0.003	0.997	0.000
G83.0 Diplegia of upper limbs	0.003	0.997	0.000
S22.4 Multiple fractures of ribs	0.003	0.997	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.997	0.003
G83.1 Monoplegia of lower limb	0.003	0.997	0.000
M50.0 Cervical disk disorder with myelopathy	0.003	0.997	0.000
S22.01 Fracture of thoracic vertebra (open)	0.002	0.997	0.000
S22.9 Fracture of bony thorax, part unspecified	0.002	0.997	0.000
S22.8 Fracture of other parts of bony thorax	0.002	0.997	0.000
G80 Infantile cerebral palsy	0.002	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
O36.5 Maternal care for poor foetal growth	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
G35 Multiple sclerosis	0.002	0.998	0.000
S22.21 Fracture of sternum (open)	0.002	0.998	0.000
E14.8 With unspecified complications	0.000	0.998	0.002
E14.7 With multiple complications	0.000	0.998	0.002
E14.6 With other specified complications	0.000	0.998	0.002
E14.5 With peripheral circulatory complications	0.000	0.998	0.002
E14.4 With neurological complications	0.000	0.998	0.002
E14.2 Withrenal complications	0.000	0.998	0.002
E14.1 With ketoacidosis	0.000	0.998	0.002
E14.0 With coma	0.000	0.998	0.002
S22.5 Flail chest	0.002	0.998	0.000
S22.40 Multiple fractures of ribs (closed)	0.002	0.998	0.000
M67.4 Ganglion	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
S22.1 Multiple fractures of thoracic spine	0.002	0.998	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.002	0.998	0.000
S32.5 Fracture of pubis	0.002	0.998	0.000
W19.8 Other specified place	0.000	0.998	0.002
W19.5 Trade and service area	0.000	0.998	0.002
W19.0 Home	0.000	0.998	0.002
W19.7 Farm	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
O36.8 Maternal care for other specified foetal problems	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Chapter VI Diseases of the nervous system	0.002	0.998	0.000
S22.41 Multiple fractures of ribs (open)	0.002	0.998	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
M67.1 Other contracture of tendon (sheath)	0.002	0.998	0.000
W19.1 Residential institution	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
E10.4 With neurological complications	0.000	0.998	0.002
W19.6 Industrial and construction area	0.000	0.998	0.002
Y46.4 Iminostilbenes	0.002	0.998	0.000
Z50.5 Speech therapy	0.002	0.998	0.000
E14.3 With ophthalmic complications	0.000	0.998	0.002
H43.8 Other disorders of vitreous body	0.000	0.998	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.002	0.998	0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
S22.81 Fracture of other parts of bony thorax (open)	0.002	0.998	0.000
S22.80 Fracture of other parts of bony thorax (closed)	0.002	0.998	0.000
S22.91 Fracture of bony thorax, part unspecified (open)	0.002	0.998	0.000
S22.90 Fracture of bony thorax, part unspecified (closed)	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.002	0.998	0.000
G80.8 Other infantile cerebral palsy	0.002	0.998	0.000
G80.4 Ataxic cerebral palsy	0.002	0.998	0.000
G80.3 Dyskinetic cerebral palsy	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.002	0.998	0.000
G80.1 Spastic diplegia	0.002	0.998	0.000
G80.0 Spastic cerebral palsy	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.998	0.002
O80.9 Single spontaneous delivery, unspecified	0.000	0.998	0.002
W19.3 Sports and athletics area	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Z35.4 Supervision of pregnancy with grand multiparity	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
M67.2 Synovial hypertrophy, not elsewhere classified	0.002	0.998	0.000
M67 Other disorders of synovium and tendon	0.002	0.998	0.000
Z35 Supervision of high-risk pregnancy	0.002	0.998	0.000
G83.4 Cauda equina syndrome	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
S22.51 Flail chest (open)	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.002	0.998	0.000
M67.49 Ganglion, multiple sites	0.002	0.998	0.000
M67.47 Ganglion, ankle and foot	0.002	0.998	0.000
M67.45 Ganglion, hip	0.002	0.998	0.000
S22.11 Multiple fractures of thoracic spine (open)	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
W19.09 Unspecified fall; Home; During unspecified activity	0.000	0.998	0.002
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.000	0.998	0.002
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.000	0.998	0.002
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.000	0.998	0.002
G09 Sequelae of inflammatory diseases of central nervous system	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
S32.51 Fracture of pubis (open)	0.002	0.998	0.000
E87.2 Acidosis	0.002	0.998	0.000
M43.1 Spondylolisthesis	0.000	0.998	0.002
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.002	0.998	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.998	0.002
G99 Other disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
O36 Maternal care for other known or suspected foetal problems	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
H81.0 Meniere's disease	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.998	0.002
O36.9 Maternal care for foetal problem, unspecified	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Chapter VIII Diseases of the ear and mastoid process	0.000	0.998	0.002
S32.10 Fracture of sacrum (closed)	0.002	0.998	0.000
K51.4 Pseudopolyposis of colon	0.002	0.998	0.000
R04.2 Haemoptysis	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
Z49.0 Preparatory care for dialysis	0.000	0.998	0.002
S22.50 Flail chest (closed)	0.002	0.998	0.000
W19.4 Street and highway	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
E10-E14 Diabetes mellitus	0.000	0.998	0.002
Y40.0 Penicillins	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
G36 Other acute disseminated demyelination	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.001	0.998	0.000
E13.9 Without complications	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
E13 Other specified diabetes mellitus	0.000	0.998	0.002
G06 Intracranial and intraspinal abscess and granuloma	0.002	0.998	0.000
G70-G73 Diseases of myoneural junction and muscle	0.002	0.998	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.000	0.998	0.002
S22.10 Multiple fractures of thoracic spine (closed)	0.002	0.998	0.000
W19.2 School, other institution and public administrative area	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
M67.9 Disorder of synovium and tendon, unspecified	0.002	0.998	0.000
M67.3 Transient synovitis	0.002	0.998	0.000
M67.0 Short Achilles tendon (acquired)	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.000	0.998	0.002
Y54.5 Other diuretics	0.002	0.998	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.002	0.998	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.002	0.998	0.000
Z35.6 Supervision of very young primigravida	0.002	0.998	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.002	0.998	0.000
E10.2 With renal complications	0.000	0.998	0.002
G12.2 Motor neuron disease	0.000	0.998	0.001
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.002	0.998	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
G00 Bacterial meningitis, not elsewhere classified	0.002	0.998	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.002	0.998	0.000
C80.9 Malignant neoplasm, unspecified	0.000	0.998	0.002
X50.4 Street and highway	0.002	0.998	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.002	0.998	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.002	0.998	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.002	0.998	0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.998	0.002
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.998	0.002
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.998	0.002
M43.12 Spondylolisthesis (Cervical region)	0.000	0.998	0.002
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.000	0.998	0.002
M43.10 Spondylolisthesis (Multiple sites in spine)	0.000	0.998	0.002
E10.8 With unspecified complications	0.000	0.998	0.002
E10.7 With multiple complications	0.000	0.998	0.002
E10.6 With other specified complications	0.000	0.998	0.002
E10.0 With coma	0.000	0.998	0.002
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.002	0.998	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.002	0.998	0.000
O36.2 Maternal care for hydrops foetalis	0.002	0.998	0.000
O36.1 Maternal care for other isoimmunisation	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.1 Benzodiazepines	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.998	0.000
Y50.8 Other central nervous system stimulants	0.001	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.998	0.000
Y50.1 Opioid receptor antagonists	0.001	0.998	0.000
Y50.0 Analeptics	0.001	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.998	0.000
Y58.5 Diphtheria vaccine	0.001	0.998	0.000
Y58.4 Tetanus vaccine	0.001	0.998	0.000
Y58.3 Plague vaccine	0.001	0.998	0.000
Y58.2 Cholera vaccine	0.001	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.998	0.000
Y58.0 BCG vaccine	0.001	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.998	0.000
Y59.3 Immunoglobulin	0.001	0.998	0.000
Y59.2 Protozoal vaccines	0.001	0.998	0.000
Y59.1 Rickettsial vaccines	0.001	0.998	0.000
Y59.0 Viral vaccines	0.001	0.998	0.000
H80-H83 Diseases of inner ear	0.000	0.998	0.002
K55.0 Acute vascular disorders of intestine	0.002	0.998	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.998	0.002
E10.3 With ophthalmic complications	0.000	0.998	0.002
M67.8 Other specified disorders of synovium and tendon	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.001	0.998	0.000
G82 Paraplegia and tetraplegia	0.001	0.998	0.000
H81 Disorders of vestibular function	0.000	0.998	0.002
N36.2 Urethral caruncle	0.000	0.998	0.002
Z35.8 Supervision of other high-risk pregnancies	0.002	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.001	0.998	0.001
G06.1 Intraspinal abscess and granuloma	0.001	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.001
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
S32.1 Fracture of sacrum	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.998	0.002
E10.5 With peripheral circulatory complications	0.000	0.998	0.002
G57.8 Other mononeuropathies of lower limb	0.002	0.998	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.998	0.001
H80 Otosclerosis	0.000	0.998	0.002
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.998	0.002
G36.9 Acute disseminated demyelination, unspecified	0.001	0.998	0.000
G36.8 Other specified acute disseminated demyelination	0.001	0.998	0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]	0.001	0.998	0.000
G36.0 Neuromyelitis optica [Devic]	0.001	0.998	0.000
J05.1 Acute epiglottitis	0.002	0.998	0.000
K86.3 Pseudocyst of pancreas	0.000	0.998	0.002
G04 Encephalitis, myelitis and encephalomyelitis	0.001	0.998	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.000	0.998	0.002
E13.8 With unspecified complications	0.000	0.998	0.001
E13.7 With multiple complications	0.000	0.998	0.001
E13.6 With other specified complications	0.000	0.998	0.001
E13.5 With peripheral circulatory complications	0.000	0.998	0.001
E13.4 With neurological complications	0.000	0.998	0.001
E13.3 With ophthalmic complications	0.000	0.998	0.001
E13.2 With renal complications	0.000	0.998	0.001
E13.1 With ketoacidosis	0.000	0.998	0.001
E13.0 With coma	0.000	0.998	0.001
G06.2 Extradural and subdural abscess, unspecified	0.001	0.998	0.000
N48.1 Balanoposthitis	0.000	0.998	0.002
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.001	0.998	0.000
G14 Postpolio syndrome	0.001	0.998	0.000
G10 Huntington's disease	0.001	0.998	0.000
G30 Alzheimer's disease	0.000	0.998	0.001
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.001	0.998	0.000
G06.0 Intracranial abscess and granuloma	0.001	0.998	0.000
Y52.1 Calcium-channel blockers	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations